What is LSPediA?
Founded in 2013, LSPediA operates at the intersection of pharmaceutical logistics and regulatory technology. The company provides a comprehensive suite of turnkey solutions, including its flagship OneScan platform, which serves as the industry benchmark for Drug Supply Chain Security Act (DSCSA) compliance. Beyond mere regulatory adherence, the firm offers the Investigator software, a pioneering collaborative tool designed to automate the resolution of complex transaction data and logistics exceptions. By integrating business intelligence with real-time traceability, LSPediA enables pharmaceutical manufacturers, wholesalers, and dispensers to mitigate operational risks while enhancing supply chain transparency. Its market position is defined by a focus on high-stakes compliance, where the cost of failure is significant, making its automated, cloud-based architecture an essential component of modern pharmaceutical operations.
How much funding has LSPediA raised?
LSPediA has raised a total of $357K across 2 funding rounds:
Debt
$150K
Debt
$207K
Debt (2020): $150K with participation from PPP
Debt (2021): $207K led by PPP
Key Investors in LSPediA
PPP
Public-Private Partnership
What's next for LSPediA?
With this late-stage capital injection, LSPediA is well-positioned to accelerate its product roadmap and expand its footprint in the global life sciences sector. The strategic focus will likely shift toward deepening the integration of artificial intelligence within its Investigator platform to further reduce manual intervention in exception management. As the regulatory landscape for pharmaceutical traceability becomes increasingly complex, the company is expected to leverage its financial backing to enhance its interoperability features, ensuring seamless data exchange across disparate supply chain nodes. Furthermore, the firm may explore inorganic growth opportunities or strategic partnerships to broaden its service offerings, ultimately aiming to become the definitive operating system for pharmaceutical supply chain integrity and operational excellence.
See full LSPediA company page